Doripenem | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Doripenem
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Doripenem

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

18 API Suppliers, 5 USDMF, 1 EU WC, 2 KDMF, 13 Listed Suppliers, $ API Reference Price

18 API Suppliers
5 USDMF
1 EU WC
2 KDMF
13 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

17 FDF Dossiers, 2 FDA Orange Book, 1 South Africa, 14 Listed Dossiers

17 FDF Dossiers
2 FDA Orange Book
1 South Africa
14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INTRAVENOUS - 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INTRAVENOUS - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INTRAVENOUS - 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INTRAVENOUS - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

MARKET PLACE

8 APIs, 4 FDF Dossiers

8 APIs
4 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 Health Canada Patents

3 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 Others

5 Others

$ API Ref.Price (USD/KG) : 7,224 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 3Janssen Inc.

filter Patent Reset all filters

3 All

01 12076430

02 12188529

03 12404703

filter Product Reset all filters

3 All

01 3Doripenem Monohydrate

filter Dosage Reset all filters

3 All

01 3Sterile Powder for Injection

filter Exp Date Reset all filters

3 All

01 12012-08-19

02 12015-04-28

03 12021-03-30

Product Main Page

01

Janssen Inc.

Doripenem

Peptide Process CMC

Not Confirmed

Janssen Inc.

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-08-19

Date Granted : 1997-12-23

Brand Name : DORIBAX

Patent Number : 2076430

Filing Date : 1992-08-19

Strength per Unit : 500 mg / vial

Dosage Form : Sterile Powder for Injection

Human Or VET : Human

Route of Administration : IV infusion

Patent Expiration Date : 2012-08-19

Date Granted : 1997-12-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Janssen Inc.

Doripenem

Peptide Process CMC

Not Confirmed

Janssen Inc.

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-04-28

Date Granted : 2005-12-06

Brand Name : DORIBAX

Patent Number : 2188529

Filing Date : 1995-04-28

Strength per Unit : 500 mg / vial

Dosage Form : Sterile Powder for Injection

Human Or VET : Human

Route of Administration : IV infusion

Patent Expiration Date : 2015-04-28

Date Granted : 2005-12-06

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Janssen Inc.

Doripenem

Peptide Process CMC

Not Confirmed

Janssen Inc.

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-03-30

Date Granted : 2007-06-05

Brand Name : DORIBAX

Patent Number : 2404703

Filing Date : 2001-03-30

Strength per Unit : 500 mg / vial

Dosage Form : Sterile Powder for Injection

Human Or VET : Human

Route of Administration : IV infusion

Patent Expiration Date : 2021-03-30

Date Granted : 2007-06-05

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!